Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3307899457;99458;99459 chr2:178538597;178538596;178538595chr2:179403324;179403323;179403322
N2AB3143794534;94535;94536 chr2:178538597;178538596;178538595chr2:179403324;179403323;179403322
N2A3051091753;91754;91755 chr2:178538597;178538596;178538595chr2:179403324;179403323;179403322
N2B2401372262;72263;72264 chr2:178538597;178538596;178538595chr2:179403324;179403323;179403322
Novex-12413872637;72638;72639 chr2:178538597;178538596;178538595chr2:179403324;179403323;179403322
Novex-22420572838;72839;72840 chr2:178538597;178538596;178538595chr2:179403324;179403323;179403322
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: E
  • RefSeq wild type transcript codon: GAG
  • RefSeq wild type template codon: CTC
  • Domain: Fn3-129
  • Domain position: 81
  • Structural Position: 113
  • Q(SASA): 0.5309
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
E/K rs771047688 0.716 0.885 N 0.454 0.249 0.272205846399 gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 0 None 0 8.89E-06 0
E/K rs771047688 0.716 0.885 N 0.454 0.249 0.272205846399 gnomAD-4.0.0 1.59165E-06 None None None None I None 0 0 None 0 0 None 0 0 2.85892E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
E/A 0.1855 likely_benign 0.2207 benign -0.213 Destabilizing 0.939 D 0.511 neutral N 0.45040837 None None I
E/C 0.9225 likely_pathogenic 0.9385 pathogenic 0.034 Stabilizing 0.999 D 0.685 prob.neutral None None None None I
E/D 0.1549 likely_benign 0.1883 benign -0.257 Destabilizing 0.939 D 0.415 neutral N 0.459182569 None None I
E/F 0.9051 likely_pathogenic 0.9265 pathogenic -0.147 Destabilizing 0.993 D 0.609 neutral None None None None I
E/G 0.228 likely_benign 0.2731 benign -0.384 Destabilizing 0.982 D 0.469 neutral N 0.475589242 None None I
E/H 0.6608 likely_pathogenic 0.7225 pathogenic 0.18 Stabilizing 0.998 D 0.371 neutral None None None None I
E/I 0.5194 ambiguous 0.5772 pathogenic 0.194 Stabilizing 0.973 D 0.539 neutral None None None None I
E/K 0.2137 likely_benign 0.258 benign 0.486 Stabilizing 0.885 D 0.454 neutral N 0.483790225 None None I
E/L 0.5931 likely_pathogenic 0.6666 pathogenic 0.194 Stabilizing 0.91 D 0.552 neutral None None None None I
E/M 0.6477 likely_pathogenic 0.706 pathogenic 0.215 Stabilizing 0.998 D 0.563 neutral None None None None I
E/N 0.3775 ambiguous 0.4608 ambiguous 0.156 Stabilizing 0.986 D 0.387 neutral None None None None I
E/P 0.6132 likely_pathogenic 0.6782 pathogenic 0.078 Stabilizing 0.993 D 0.468 neutral None None None None I
E/Q 0.2029 likely_benign 0.2433 benign 0.198 Stabilizing 0.322 N 0.363 neutral N 0.508648597 None None I
E/R 0.3861 ambiguous 0.4521 ambiguous 0.655 Stabilizing 0.973 D 0.385 neutral None None None None I
E/S 0.2584 likely_benign 0.3119 benign 0.024 Stabilizing 0.953 D 0.443 neutral None None None None I
E/T 0.3315 likely_benign 0.395 ambiguous 0.171 Stabilizing 0.953 D 0.471 neutral None None None None I
E/V 0.3352 likely_benign 0.3836 ambiguous 0.078 Stabilizing 0.322 N 0.488 neutral N 0.466436615 None None I
E/W 0.9672 likely_pathogenic 0.9768 pathogenic -0.035 Destabilizing 0.999 D 0.698 prob.neutral None None None None I
E/Y 0.8254 likely_pathogenic 0.865 pathogenic 0.093 Stabilizing 0.998 D 0.575 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.